<DOC>
	<DOCNO>NCT00264615</DOCNO>
	<brief_summary>Pharmacokinetic ( PK ) study characterize change serum concentration epilepsy patient switch LAMICTAL immediate-release extended-release vice versa .</brief_summary>
	<brief_title>Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Inclusion criterion : Confident diagnosis epilepsy . Currently LAMICTAL 2 concomitant AEDs ( antiepileptic drug ) . Females childbearing potential hormonal contraceptive hormone replacement therapy .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>daily dose</keyword>
	<keyword>seizure</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>epilepsy</keyword>
</DOC>